Northern Institute for Cancer Research

Adult Cancer

Adult Cancer

Interrogating signalling pathways to develop targeted therapies for adult cancer.

Prostate tissue section

We are working to better understand aberrant signalling pathways in adult cancers. We use state-of-the-art techniques to identify unique components of cancer cells that can be exploited to develop 'molecularly targeted therapies'. 

Our vision

We aim to develop novel therapies that:

  • are specific for cancer cells 
  • have little or no side-effects
  • are well tolerated by adult cancer patients

We aim to deliver these into clinics for the benefit of patients.

Our research areas

We have team leaders working in the following research areas:

We have particular strength in the following cancers: bladder, breast, adult leukaemia, hepatobiliary cancer, ovarian, prostate and sarcoma.

Clinical trials in adults

We have run clinical trials for Bladder cancer, Hepatocellular cancer, and Sarcoma.